Patents/Assignees

ORCA Therapeutics B.V.

1 patent in portfolio

US12233096utility2025
Recombinant Replication Competent Viruses Comprising a Coding Region for Glycogen Synthase Kinase-3 (GSK3) and Methods of Killing Aberrant Cells
0 cites